Prof David Moore

Dr David MooreTel: 020 3447 5972
Email: davidajmoore1@nhs.net

Location:
Hospital for Tropical Diseases

Specialities:
Infectious and tropical diseases

Professional background

  • Consultant in Infectious Diseases and Tropical Medicine UCLH
  • Professor in Infectious Diseases and Tropical Medicine, LSHTM
  • Honorary Reader, Imperial College London since 2010
  • Consultant Imperial College and Hammersmith Hospital London, 2002 – 2009
  • Associate Johns Hopkins School of Public Health, Baltimore, USA since 2004
  • Visiting Professor Universidad Peruana Cayetano Heredia, Lima, Peru since 2002

Research interests

  • tuberculosis - diagnostics, infection control, TB-DM, MDRTB
  • Chagas disease in Latin American migrants
  • bartonellosis

Publications

Reddy KP, Brady MF, Gilman RH, Coronel J, Navincopa M, Ticona E, Chavez G, Sánchez E, Rojas C, Solari L, Valencia J, Pinedo Y, Benites C, Friedland JS, Moore DA.  Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.  CID 2010 50(7):988-96

Escombe AR, Moore DA, Gilman RH, Navincopa M, Ticona E, Mitchell B, Noakes C, Martínez C, Sheen P, Ramirez R, Quino W, Gonzalez A, Friedland JS, Evans CA.  Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission.  PloS Med 2009 6(3):e43

Escombe AR, Moore DA, Gilman RH, Pan W, Navincopa M, Ticona E, Martínez C, Caviedes L, Sheen P, Gonzalez A, Noakes CJ, Friedland JS, Evans CA. The infectiousness of tuberculosis patients coinfected with HIV. PloS Med 2008 5(9):e188

Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Piñedo Y, Saravia JC, Salazar C, Oberhelman R, Hollm-Delgado MG, LaChira D, Escombe AR, Friedland JS.  Microscopic-observation drug-susceptibility assay for the diagnosis of TB. NEJM 2006 355(15):1539-50.

Vargas D, García L, Gilman RH, Evans C, Ticona E, Navincopa M, Luo RF, Caviedes L, Hong C, Escombe R, Moore DA.  Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru.  Lancet 2005 365(9454):150-2

GMC/GDC number: 3317721